Human Cord Blood CD4+CD25hi Regulatory T Cells Suppress Prenatally Acquired T Cell Responses to Plasmodium falciparum Antigens

Center for Global Health and Diseases, Case Western Reserve University, Cleveland, OH 44106, USA.
The Journal of Immunology (Impact Factor: 4.92). 03/2011; 186(5):2780-91. DOI: 10.4049/jimmunol.1001188
Source: PubMed


In malaria endemic regions, a fetus is often exposed in utero to Plasmodium falciparum blood-stage Ags. In some newborns, this can result in the induction of immune suppression. We have previously shown these modulated immune responses to persist postnatally, with a subsequent increase in a child's susceptibility to infection. To test the hypothesis that this immune suppression is partially mediated by malaria-specific regulatory T cells (T(regs)) in utero, cord blood mononuclear cells (CBMC) were obtained from 44 Kenyan newborns of women with and without malaria at delivery. CD4(+)CD25(lo) T cells and CD4(+)CD25(hi) FOXP3(+) cells (T(regs)) were enriched from CBMC. T(reg) frequency and HLA-DR expression on T(regs) were significantly greater for Kenyan as compared with North American CBMC (p < 0.01). CBMC/CD4(+) T cells cultured with P. falciparum blood-stage Ags induced production of IFN-γ, IL-13, IL-10, and/or IL-5 in 50% of samples. Partial depletion of CD25(hi) cells augmented the Ag-driven IFN-γ production in 69% of subjects with malaria-specific responses and revealed additional Ag-reactive lymphocytes in previously unresponsive individuals (n = 3). Addition of T(regs) to CD4(+)CD25(lo) cells suppressed spontaneous and malaria Ag-driven production of IFN-γ in a dose-dependent fashion, until production was completely inhibited in most subjects. In contrast, T(regs) only partially suppressed malaria-induced Th2 cytokines. IL-10 or TGF-β did not mediate this suppression. Thus, prenatal exposure to malaria blood-stage Ags induces T(regs) that primarily suppress Th1-type recall responses to P. falciparum blood-stage Ags. Persistence of these T(regs) postnatally could modify a child's susceptibility to malaria infection and disease.

1 Follower
9 Reads
  • Source
    • "Finally, such small parasite components may be able to cross the placental barrier and thus explain and contribute to the induction of Tregs in cord blood even in the absence of direct cord blood parasitemia. Indeed, in some studies levels of Tregs have been found to be elevated in neonates born to mothers who had experienced malaria episodes during pregnancy (Brustoski et al., 2006; Mackroth et al., 2011), while in other studies, ex vivo cord blood Treg frequencies were unaffected by placental malaria and only increased only upon in vitro stimulation with iRBC extract (Flanagan et al., 2010; Soulard et al., 2011). It is yet unclear whether Treg induction during a single Plasmodium infection predisposes the immune system to heightened regulatory responses at the next encounter with the parasite, but in utero exposure to Treg-inducing parasite components may prime the fetus's immune system to respond with a less inflammatory response upon re-exposure to malaria-antigens (Malhotra et al., 2009; Flanagan et al., 2010). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Elevated levels of regulatory T cells following Plasmodium infection are a well-reported phenomenon that can influence both protective and pathological anti-parasite responses, and might additionally impact on vaccine responses in acutely malaria infected individuals. The mechanisms underlying their induction or expansion by the parasite, however, are incompletely understood. In a previous study, Plasmodium falciparum infected red blood cells (iRBCs) were shown to induce effector-cytokine producing Foxp3int CD4+ T cells, as well as regulatory Foxp3hi CD4+ T cells in vitro. The aim of the present study was to determine the contribution of parasite components to the induction of Foxp3 expression in human CD4+ T cells. Using the surface PfEMP1-deficient parasite line 1G8, we demonstrate that induction of Foxp3hi and Foxp3int CD4+ T cells is independent of PfEMP1 expression on iRBCs. We further demonstrate that integrity of iRBCs is no requirement for the induction of Foxp3 expression. Finally, transwell experiments showed that induction of Foxp3 expression, and specifically the generation of Foxp3hi as opposed to Foxp3int CD4 T cells, can be mediated by soluble parasite components smaller than 20 nm and thus likely distinct from the malaria pigment hemozoin. These results suggest that the induction of Foxp3hi T cells by P. falciparum is largely independent of two key immune modulatory parasite components, and warrant future studies into the nature of the Foxp3hi inducing parasite components to potentially allow their exclusion from vaccine formulations.
    Frontiers in Microbiology 05/2014; 5:200. DOI:10.3389/fmicb.2014.00200 · 3.99 Impact Factor
  • Source
    • "Other immunoregulatory networks likely exist with heavy infections such as development of atypical and potentially suppressive B cells (Pierce, 2009; Weiss et al., 2009) and suppression of antigen-presenting cell functions akin to endotoxin tolerance (Boutlis et al., 2006). Immune tolerance can also result from in utero exposure to malaria or their soluble products (King et al., 2002; Mackroth et al., 2011; Malhotra et al., 2008, 2009; Metenou et al., 2007) that can persist into early childhood (Malhotra et al., 2009). Malaria in pregnancy is much less common and if present, is less likely to cause altered placental dysfunction for Pv compared to Pf (Rogerson et al., 2007; ter Kuile and Rogerson, 2008). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Population studies show that individuals acquire immunity to Plasmodium vivax more quickly than Plasmodium falciparum irrespective of overall transmission intensity, resulting in the peak burden of P. vivax malaria in younger age groups. Similarly, actively induced P. vivax infections in malaria therapy patients resulted in faster and generally more strain-transcending acquisition of immunity than P. falciparum infections. The mechanisms behind the more rapid acquisition of immunity to P. vivax are poorly understood. Natural acquired immune responses to P. vivax target both pre-erythrocytic and blood-stage antigens and include humoral and cellular components. To date, only a few studies have investigated the association of these immune responses with protection, with most studies focussing on a few merozoite antigens (such as the Pv Duffy binding protein (PvDBP), the Pv reticulocyte binding proteins (PvRBPs), or the Pv merozoite surface proteins (PvMSP1, 3 & 9)) or the circumsporozoite protein (PvCSP). Naturally acquired transmission-blocking (TB) immunity (TBI) was also found in several populations. Although limited, these data support the premise that developing a multi-stage P. vivax vaccine may be feasible and is worth pursuing.
    Advances in Parasitology 02/2013; 81:77-131. DOI:10.1016/B978-0-12-407826-0.00003-5 · 6.23 Impact Factor
  • Source
    • "The abnormal production of Tregs could also represent an immunosuppressing factor in itself. Indeed, several studies now indicate that an excessive Treg presence may impede immuno-surveillance against tumor cells and may suppress the ability of CD4 + effector T cells to, for example, eliminate parasites (Belkaid et al., 2002; Mackroth et al., 2011). More recently, the contribution of regulatory B cells in experimental stroke has been uncovered (Ren et al., 2011). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Neurological disorders affect over one billion lives each year worldwide. With population aging, this number is on the rise, making neurological disorders a major public health concern. Within this category, stroke represents the second leading cause of death, ranking after heart disease, and is associated with long-term physical disabilities and impaired quality of life. In this review, we will focus our attention on examining the tight crosstalk between brain and immune system and how disruption of this mutual interaction is at the basis of stroke pathophysiology. We will also explore the emerging literature in support of the use of immuno-modulatory molecules as potential therapeutic interventions in stroke.
    Molecular and Cellular Neuroscience 08/2012; 53. DOI:10.1016/j.mcn.2012.08.011 · 3.84 Impact Factor
Show more


9 Reads
Available from